FDA Approved: EPRONTIA — Supplemental Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for EPRONTIA (topiramate) submitted by Azurity Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Migraine

Drugs mentioned

• EPRONTIA (Topiramate)

Snippet

SUPPL AP for EPRONTIA (TOPIRAMATE)